Login to Your Account



EPIX Medical Files NDA For Its Blood-Pool Agent MS-325

By Kim Coghill


Wednesday, December 17, 2003
EPIX Medical Inc. filed its first new drug application along with partner, Schering AG, for a blood-pool agent called MS-325 for vascular imaging with magnetic resonance angiography. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription